Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study

Table 2

Final visual improvement for anti-VEGF injection and pars plana vitrectomy with ILM peeling monotherapy.

	Anti-VEGF; ()	PPV-ILM; ()	value
≥3 line improvement	31.3%	55.2%	0.0031
≥6 line improvement	10.8%	29.3%	0.003

VEGF = vascular endothelial growth factor.
PPV-ILM = pars plana vitrectomy with internal limiting membrane peeling.